Home/Filings/4/0001209191-21-023838
4//SEC Filing

HANLY ANN M. 4

Accession 0001209191-21-023838

CIK 0001706431other

Filed

Mar 30, 8:00 PM ET

Accepted

Mar 31, 6:17 PM ET

Size

7.0 KB

Accession

0001209191-21-023838

Insider Transaction Report

Form 4
Period: 2021-03-29
HANLY ANN M.
EVP & Chief Technology Officer
Transactions
  • Award

    Common Stock

    2021-03-29+30,00030,000 total
  • Award

    Employee Stock Option (Right to Buy)

    2021-03-29+60,00060,000 total
    Exercise: $48.38Exp: 2031-03-28Common Stock (60,000 underlying)
Footnotes (1)
  • [F1]1/4 of the shares subject to the stock option vest and become exercisable on March 29, 2022, and the remainder vest in 36 equal monthly installments thereafter.

Issuer

Vir Biotechnology, Inc.

CIK 0001706431

Entity typeother

Related Parties

1
  • filerCIK 0001854528

Filing Metadata

Form type
4
Filed
Mar 30, 8:00 PM ET
Accepted
Mar 31, 6:17 PM ET
Size
7.0 KB